English
简体中文
Total: £ 56.28
Published Date: 2026-05-15 | Pages: 121 | Tables: 125 | Medical Care
The global mRNA Synthesis Kit market was valued at US$ 1351 million in 2025 and is anticipated to reach US$ 2142 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on mRNA Synthesis Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An mRNA Synthesis Kit is a laboratory reagent system used to produce messenger RNA (mRNA) in vitro. It typically contains templates, enzymes (such as RNA polymerase), nucleotides, and buffers required for the transcription process, enabling the synthesis, capping, and sometimes modification of mRNA for research, therapeutic development, or vaccine production.In 2025, global mRNA Synthesis Kit production reached approximately 730,100 units, with an average global market price of around US$ 1,850 per unit. Annual production capacity is 812,000 units. Gross Profit Margin: 68%.The mRNA Synthesis Kit industry sits in the upstream segment of the broader mRNA therapeutics ecosystem. The supply chain starts from raw materials such as nucleotides, enzymes (e.g., T7 RNA polymerase), and DNA templates, which are produced by specialized biotech reagent manufacturers. These components are assembled into IVT (in vitro transcription) kits by core suppliers, then distributed to academic labs, biotech companies, and pharmaceutical firms. Downstream users apply these kits in vaccine development, cell therapy, and gene function research, often integrating them into larger workflows that may include mRNA purification, modification, and lipid nanoparticle (LNP) delivery systems.mRNA Synthesis Kits represent a high-value, structurally stable reagent segment rather than a high-growth consumer-like market. The key value lies in technological control of enzymatic systems and workflow integration rather than raw volume expansion. While demand is strongly driven by mRNA vaccines and cell therapy pipelines, the market remains concentrated among a few global suppliers due to technical barriers in enzyme engineering and capping chemistry. Over time, competition is expected to shift from basic IVT kits toward integrated, GMP-grade, and high-efficiency mRNA production platforms.
The North American market for mRNA Synthesis Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for mRNA Synthesis Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of mRNA Synthesis Kit include Thermo Fisher Scientific, New England Biolabs (NEB), Promega Corporation, Merck KGaA, TriLink BioTechnologies, Integrated DNA Technologies, Takara Bio, Qiagen, GenScript Biotech, Zymo Research, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global mRNA Synthesis Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding mRNA Synthesis Kit. The mRNA Synthesis Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global mRNA Synthesis Kit market comprehensively. Regional market sizes by Purity / Regulatory Grade, by Application, by Functional Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist mRNA Synthesis Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Purity / Regulatory Grade, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
New England Biolabs (NEB)
Promega Corporation
Merck KGaA
TriLink BioTechnologies
Integrated DNA Technologies
Takara Bio
Qiagen
GenScript Biotech
Zymo Research
Vazyme Biotech
Yeasen Biotechnology
TransGen Biotech
Biomiga
Magen
Segment by Purity / Regulatory Grade
Research Grade
Preclinical Grade
Clinical Grade
GMP Grade
Segment by Functional Type
IVT Kit
Capping Kit
Poly(A) Kit
Purification Kit
All-in-one Kit
Segment by Yield Scale
Low-yield Kit (µg scale)
Medium-yield Kit (mg scale)
High-yield Kit (multi-mg to g scale)
by Application
Clinical
Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Purity / Regulatory Grade, by Application, by Functional Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for mRNA Synthesis Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines mRNA Synthesis Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Purity / Regulatory Grade, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 mRNA Synthesis Kit Market Overview
1.1 Product Definition
1.2 mRNA Synthesis Kit by Purity / Regulatory Grade
1.2.1 Global mRNA Synthesis Kit Market Value by Purity / Regulatory Grade: 2025 vs 2032
1.2.2 Research Grade
1.2.3 Preclinical Grade
1.2.4 Clinical Grade
1.2.5 GMP Grade
1.3 mRNA Synthesis Kit by Functional Type
1.3.1 Global mRNA Synthesis Kit Market Value by Functional Type: 2025 vs 2032
1.3.2 IVT Kit
1.3.3 Capping Kit
1.3.4 Poly(A) Kit
1.3.5 Purification Kit
1.3.6 All-in-one Kit
1.4 mRNA Synthesis Kit by Yield Scale
1.4.1 Global mRNA Synthesis Kit Market Value by Yield Scale: 2025 vs 2032
1.4.2 Low-yield Kit (µg scale)
1.4.3 Medium-yield Kit (mg scale)
1.4.4 High-yield Kit (multi-mg to g scale)
1.5 mRNA Synthesis Kit by Application
1.5.1 Global mRNA Synthesis Kit Market Value by Application: 2025 vs 2032
1.5.2 Clinical
1.5.3 Research
1.5.4 Others
1.6 Global mRNA Synthesis Kit Market Size Estimates and Forecasts
1.6.1 Global mRNA Synthesis Kit Revenue 2021–2032
1.6.2 Global mRNA Synthesis Kit Sales 2021–2032
1.6.3 Global mRNA Synthesis Kit Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 mRNA Synthesis Kit Market Competition by Manufacturers
2.1 Global mRNA Synthesis Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global mRNA Synthesis Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global mRNA Synthesis Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of mRNA Synthesis Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of mRNA Synthesis Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of mRNA Synthesis Kit, Product Types and Applications
2.7 Global Key Manufacturers of mRNA Synthesis Kit, Date of Entry into the Industry
2.8 Global mRNA Synthesis Kit Market Competitive Situation and Trends
2.8.1 Global mRNA Synthesis Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global mRNA Synthesis Kit Players Market Share by Revenue
2.8.3 Global mRNA Synthesis Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Synthesis Kit Market Scenario by Region
3.1 Global mRNA Synthesis Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global mRNA Synthesis Kit Sales by Region: 2021–2032
3.2.1 Global mRNA Synthesis Kit Sales by Region: 2021–2026
3.2.2 Global mRNA Synthesis Kit Sales by Region: 2027–2032
3.3 Global mRNA Synthesis Kit Revenue by Region: 2021–2032
3.3.1 Global mRNA Synthesis Kit Revenue by Region: 2021–2026
3.3.2 Global mRNA Synthesis Kit Revenue by Region: 2027–2032
3.4 North America mRNA Synthesis Kit Market Facts & Figures by Country
3.4.1 North America mRNA Synthesis Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America mRNA Synthesis Kit Sales by Country (2021–2032)
3.4.3 North America mRNA Synthesis Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Synthesis Kit Market Facts & Figures by Country
3.5.1 Europe mRNA Synthesis Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe mRNA Synthesis Kit Sales by Country (2021–2032)
3.5.3 Europe mRNA Synthesis Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Synthesis Kit Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Synthesis Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific mRNA Synthesis Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific mRNA Synthesis Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Synthesis Kit Market Facts & Figures by Country
3.7.1 Latin America mRNA Synthesis Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America mRNA Synthesis Kit Sales by Country (2021–2032)
3.7.3 Latin America mRNA Synthesis Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Synthesis Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Synthesis Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa mRNA Synthesis Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa mRNA Synthesis Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Purity / Regulatory Grade
4.1 Global mRNA Synthesis Kit Sales by Purity / Regulatory Grade (2021–2032)
4.1.1 Global mRNA Synthesis Kit Sales by Purity / Regulatory Grade (2021–2026)
4.1.2 Global mRNA Synthesis Kit Sales by Purity / Regulatory Grade (2027–2032)
4.1.3 Global mRNA Synthesis Kit Sales Market Share by Purity / Regulatory Grade (2021–2032)
4.2 Global mRNA Synthesis Kit Revenue by Purity / Regulatory Grade (2021–2032)
4.2.1 Global mRNA Synthesis Kit Revenue by Purity / Regulatory Grade (2021–2026)
4.2.2 Global mRNA Synthesis Kit Revenue by Purity / Regulatory Grade (2027–2032)
4.2.3 Global mRNA Synthesis Kit Revenue Market Share by Purity / Regulatory Grade (2021–2032)
4.3 Global mRNA Synthesis Kit Price by Purity / Regulatory Grade (2021–2032)
5 Segment by Application
5.1 Global mRNA Synthesis Kit Sales by Application (2021–2032)
5.1.1 Global mRNA Synthesis Kit Sales by Application (2021–2026)
5.1.2 Global mRNA Synthesis Kit Sales by Application (2027–2032)
5.1.3 Global mRNA Synthesis Kit Sales Market Share by Application (2021–2032)
5.2 Global mRNA Synthesis Kit Revenue by Application (2021–2032)
5.2.1 Global mRNA Synthesis Kit Revenue by Application (2021–2026)
5.2.2 Global mRNA Synthesis Kit Revenue by Application (2027–2032)
5.2.3 Global mRNA Synthesis Kit Revenue Market Share by Application (2021–2032)
5.3 Global mRNA Synthesis Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific mRNA Synthesis Kit Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 New England Biolabs (NEB)
6.2.1 New England Biolabs (NEB) Company Information
6.2.2 New England Biolabs (NEB) Description and Business Overview
6.2.3 New England Biolabs (NEB) mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 New England Biolabs (NEB) mRNA Synthesis Kit Product Portfolio
6.2.5 New England Biolabs (NEB) Recent Developments/Updates
6.3 Promega Corporation
6.3.1 Promega Corporation Company Information
6.3.2 Promega Corporation Description and Business Overview
6.3.3 Promega Corporation mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Promega Corporation mRNA Synthesis Kit Product Portfolio
6.3.5 Promega Corporation Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck KGaA mRNA Synthesis Kit Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 TriLink BioTechnologies
6.5.1 TriLink BioTechnologies Company Information
6.5.2 TriLink BioTechnologies Description and Business Overview
6.5.3 TriLink BioTechnologies mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 TriLink BioTechnologies mRNA Synthesis Kit Product Portfolio
6.5.5 TriLink BioTechnologies Recent Developments/Updates
6.6 Integrated DNA Technologies
6.6.1 Integrated DNA Technologies Company Information
6.6.2 Integrated DNA Technologies Description and Business Overview
6.6.3 Integrated DNA Technologies mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Integrated DNA Technologies mRNA Synthesis Kit Product Portfolio
6.6.5 Integrated DNA Technologies Recent Developments/Updates
6.7 Takara Bio
6.7.1 Takara Bio Company Information
6.7.2 Takara Bio Description and Business Overview
6.7.3 Takara Bio mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Takara Bio mRNA Synthesis Kit Product Portfolio
6.7.5 Takara Bio Recent Developments/Updates
6.8 Qiagen
6.8.1 Qiagen Company Information
6.8.2 Qiagen Description and Business Overview
6.8.3 Qiagen mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Qiagen mRNA Synthesis Kit Product Portfolio
6.8.5 Qiagen Recent Developments/Updates
6.9 GenScript Biotech
6.9.1 GenScript Biotech Company Information
6.9.2 GenScript Biotech Description and Business Overview
6.9.3 GenScript Biotech mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GenScript Biotech mRNA Synthesis Kit Product Portfolio
6.9.5 GenScript Biotech Recent Developments/Updates
6.10 Zymo Research
6.10.1 Zymo Research Company Information
6.10.2 Zymo Research Description and Business Overview
6.10.3 Zymo Research mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zymo Research mRNA Synthesis Kit Product Portfolio
6.10.5 Zymo Research Recent Developments/Updates
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Company Information
6.11.2 Vazyme Biotech Description and Business Overview
6.11.3 Vazyme Biotech mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Vazyme Biotech mRNA Synthesis Kit Product Portfolio
6.11.5 Vazyme Biotech Recent Developments/Updates
6.12 Yeasen Biotechnology
6.12.1 Yeasen Biotechnology Company Information
6.12.2 Yeasen Biotechnology Description and Business Overview
6.12.3 Yeasen Biotechnology mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Yeasen Biotechnology mRNA Synthesis Kit Product Portfolio
6.12.5 Yeasen Biotechnology Recent Developments/Updates
6.13 TransGen Biotech
6.13.1 TransGen Biotech Company Information
6.13.2 TransGen Biotech Description and Business Overview
6.13.3 TransGen Biotech mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 TransGen Biotech mRNA Synthesis Kit Product Portfolio
6.13.5 TransGen Biotech Recent Developments/Updates
6.14 Biomiga
6.14.1 Biomiga Company Information
6.14.2 Biomiga Description and Business Overview
6.14.3 Biomiga mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Biomiga mRNA Synthesis Kit Product Portfolio
6.14.5 Biomiga Recent Developments/Updates
6.15 Magen
6.15.1 Magen Company Information
6.15.2 Magen Description and Business Overview
6.15.3 Magen mRNA Synthesis Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Magen mRNA Synthesis Kit Product Portfolio
6.15.5 Magen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Synthesis Kit Industry Chain Analysis
7.2 mRNA Synthesis Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Synthesis Kit Production Mode & Process Analysis
7.4 mRNA Synthesis Kit Sales and Marketing
7.4.1 mRNA Synthesis Kit Sales Channels
7.4.2 mRNA Synthesis Kit Distributors
7.5 mRNA Synthesis Kit Customer Analysis
8 mRNA Synthesis Kit Market Dynamics
8.1 mRNA Synthesis Kit Industry Trends
8.2 mRNA Synthesis Kit Market Drivers
8.3 mRNA Synthesis Kit Market Challenges
8.4 mRNA Synthesis Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global mRNA Synthesis Kit Market Value by Purity / Regulatory Grade (US$ Million), 2025 vs 2032
Table 2. Global mRNA Synthesis Kit Market Value by Functional Type (US$ Million), 2025 vs 2032
Table 3. Global mRNA Synthesis Kit Market Value by Yield Scale (US$ Million), 2025 vs 2032
Table 4. Global mRNA Synthesis Kit Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global mRNA Synthesis Kit Market Competitive Situation by Manufacturers in 2025
Table 6. Global mRNA Synthesis Kit Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global mRNA Synthesis Kit Sales Market Share by Manufacturers (2021–2026)
Table 8. Global mRNA Synthesis Kit Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global mRNA Synthesis Kit Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market mRNA Synthesis Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of mRNA Synthesis Kit, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of mRNA Synthesis Kit, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of mRNA Synthesis Kit, Product Types and Applications
Table 14. Global Key Manufacturers of mRNA Synthesis Kit, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global mRNA Synthesis Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on mRNA Synthesis Kit Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global mRNA Synthesis Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global mRNA Synthesis Kit Sales by Region (K Units), 2021–2026
Table 20. Global mRNA Synthesis Kit Sales Market Share by Region (2021–2026)
Table 21. Global mRNA Synthesis Kit Sales by Region (K Units), 2027–2032
Table 22. Global mRNA Synthesis Kit Sales Market Share by Region (2027–2032)
Table 23. Global mRNA Synthesis Kit Revenue by Region (US$ Million), 2021–2026
Table 24. Global mRNA Synthesis Kit Revenue Market Share by Region (2021–2026)
Table 25. Global mRNA Synthesis Kit Revenue by Region (US$ Million), 2027–2032
Table 26. Global mRNA Synthesis Kit Revenue Market Share by Region (2027–2032)
Table 27. North America mRNA Synthesis Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America mRNA Synthesis Kit Sales by Country (K Units), 2021–2026
Table 29. North America mRNA Synthesis Kit Sales by Country (K Units), 2027–2032
Table 30. North America mRNA Synthesis Kit Revenue by Country (US$ Million), 2021–2026
Table 31. North America mRNA Synthesis Kit Revenue by Country (US$ Million), 2027–2032
Table 32. Europe mRNA Synthesis Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe mRNA Synthesis Kit Sales by Country (K Units), 2021–2026
Table 34. Europe mRNA Synthesis Kit Sales by Country (K Units), 2027–2032
Table 35. Europe mRNA Synthesis Kit Revenue by Country (US$ Million), 2021–2026
Table 36. Europe mRNA Synthesis Kit Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific mRNA Synthesis Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific mRNA Synthesis Kit Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific mRNA Synthesis Kit Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific mRNA Synthesis Kit Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific mRNA Synthesis Kit Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America mRNA Synthesis Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America mRNA Synthesis Kit Sales by Country (K Units), 2021–2026
Table 44. Latin America mRNA Synthesis Kit Sales by Country (K Units), 2027–2032
Table 45. Latin America mRNA Synthesis Kit Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America mRNA Synthesis Kit Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa mRNA Synthesis Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa mRNA Synthesis Kit Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa mRNA Synthesis Kit Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa mRNA Synthesis Kit Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa mRNA Synthesis Kit Revenue by Country (US$ Million), 2027–2032
Table 52. Global mRNA Synthesis Kit Sales (K Units) by Purity / Regulatory Grade (2021–2026)
Table 53. Global mRNA Synthesis Kit Sales (K Units) by Purity / Regulatory Grade (2027–2032)
Table 54. Global mRNA Synthesis Kit Sales Market Share by Purity / Regulatory Grade (2021–2026)
Table 55. Global mRNA Synthesis Kit Sales Market Share by Purity / Regulatory Grade (2027–2032)
Table 56. Global mRNA Synthesis Kit Revenue (US$ Million) by Purity / Regulatory Grade (2021–2026)
Table 57. Global mRNA Synthesis Kit Revenue (US$ Million) by Purity / Regulatory Grade (2027–2032)
Table 58. Global mRNA Synthesis Kit Revenue Market Share by Purity / Regulatory Grade (2021–2026)
Table 59. Global mRNA Synthesis Kit Revenue Market Share by Purity / Regulatory Grade (2027–2032)
Table 60. Global mRNA Synthesis Kit Price (US$/Unit) by Purity / Regulatory Grade (2021–2026)
Table 61. Global mRNA Synthesis Kit Price (US$/Unit) by Purity / Regulatory Grade (2027–2032)
Table 62. Global mRNA Synthesis Kit Sales (K Units) by Application (2021–2026)
Table 63. Global mRNA Synthesis Kit Sales (K Units) by Application (2027–2032)
Table 64. Global mRNA Synthesis Kit Sales Market Share by Application (2021–2026)
Table 65. Global mRNA Synthesis Kit Sales Market Share by Application (2027–2032)
Table 66. Global mRNA Synthesis Kit Revenue (US$ Million) by Application (2021–2026)
Table 67. Global mRNA Synthesis Kit Revenue (US$ Million) by Application (2027–2032)
Table 68. Global mRNA Synthesis Kit Revenue Market Share by Application (2021–2026)
Table 69. Global mRNA Synthesis Kit Revenue Market Share by Application (2027–2032)
Table 70. Global mRNA Synthesis Kit Price (US$/Unit) by Application (2021–2026)
Table 71. Global mRNA Synthesis Kit Price (US$/Unit) by Application (2027–2032)
Table 72. Thermo Fisher Scientific Company Information
Table 73. Thermo Fisher Scientific Description and Business Overview
Table 74. Thermo Fisher Scientific mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Thermo Fisher Scientific mRNA Synthesis Kit Product
Table 76. Thermo Fisher Scientific Recent Developments/Updates
Table 77. New England Biolabs (NEB) Company Information
Table 78. New England Biolabs (NEB) Description and Business Overview
Table 79. New England Biolabs (NEB) mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. New England Biolabs (NEB) mRNA Synthesis Kit Product
Table 81. New England Biolabs (NEB) Recent Developments/Updates
Table 82. Promega Corporation Company Information
Table 83. Promega Corporation Description and Business Overview
Table 84. Promega Corporation mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Promega Corporation mRNA Synthesis Kit Product
Table 86. Promega Corporation Recent Developments/Updates
Table 87. Merck KGaA Company Information
Table 88. Merck KGaA Description and Business Overview
Table 89. Merck KGaA mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Merck KGaA mRNA Synthesis Kit Product
Table 91. Merck KGaA Recent Developments/Updates
Table 92. TriLink BioTechnologies Company Information
Table 93. TriLink BioTechnologies Description and Business Overview
Table 94. TriLink BioTechnologies mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. TriLink BioTechnologies mRNA Synthesis Kit Product
Table 96. TriLink BioTechnologies Recent Developments/Updates
Table 97. Integrated DNA Technologies Company Information
Table 98. Integrated DNA Technologies Description and Business Overview
Table 99. Integrated DNA Technologies mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Integrated DNA Technologies mRNA Synthesis Kit Product
Table 101. Integrated DNA Technologies Recent Developments/Updates
Table 102. Takara Bio Company Information
Table 103. Takara Bio Description and Business Overview
Table 104. Takara Bio mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Takara Bio mRNA Synthesis Kit Product
Table 106. Takara Bio Recent Developments/Updates
Table 107. Qiagen Company Information
Table 108. Qiagen Description and Business Overview
Table 109. Qiagen mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Qiagen mRNA Synthesis Kit Product
Table 111. Qiagen Recent Developments/Updates
Table 112. GenScript Biotech Company Information
Table 113. GenScript Biotech Description and Business Overview
Table 114. GenScript Biotech mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. GenScript Biotech mRNA Synthesis Kit Product
Table 116. GenScript Biotech Recent Developments/Updates
Table 117. Zymo Research Company Information
Table 118. Zymo Research Description and Business Overview
Table 119. Zymo Research mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Zymo Research mRNA Synthesis Kit Product
Table 121. Zymo Research Recent Developments/Updates
Table 122. Vazyme Biotech Company Information
Table 123. Vazyme Biotech Description and Business Overview
Table 124. Vazyme Biotech mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Vazyme Biotech mRNA Synthesis Kit Product
Table 126. Vazyme Biotech Recent Developments/Updates
Table 127. Yeasen Biotechnology Company Information
Table 128. Yeasen Biotechnology Description and Business Overview
Table 129. Yeasen Biotechnology mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Yeasen Biotechnology mRNA Synthesis Kit Product
Table 131. Yeasen Biotechnology Recent Developments/Updates
Table 132. TransGen Biotech Company Information
Table 133. TransGen Biotech Description and Business Overview
Table 134. TransGen Biotech mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. TransGen Biotech mRNA Synthesis Kit Product
Table 136. TransGen Biotech Recent Developments/Updates
Table 137. Biomiga Company Information
Table 138. Biomiga Description and Business Overview
Table 139. Biomiga mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Biomiga mRNA Synthesis Kit Product
Table 141. Biomiga Recent Developments/Updates
Table 142. Magen Company Information
Table 143. Magen Description and Business Overview
Table 144. Magen mRNA Synthesis Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Magen mRNA Synthesis Kit Product
Table 146. Magen Recent Developments/Updates
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. mRNA Synthesis Kit Distributors List
Table 150. mRNA Synthesis Kit Customers List
Table 151. mRNA Synthesis Kit Market Trends
Table 152. mRNA Synthesis Kit Market Drivers
Table 153. mRNA Synthesis Kit Market Challenges
Table 154. mRNA Synthesis Kit Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. Authors List of This Report
List of Figures
Figure 1. Product Picture of mRNA Synthesis Kit
Figure 2. Global mRNA Synthesis Kit Market Value by Purity / Regulatory Grade (US$ Million), 2021–2032
Figure 3. Global mRNA Synthesis Kit Market Share by Purity / Regulatory Grade: 2025 & 2032
Figure 4. Research Grade Product Picture
Figure 5. Preclinical Grade Product Picture
Figure 6. Clinical Grade Product Picture
Figure 7. GMP Grade Product Picture
Figure 8. Global mRNA Synthesis Kit Market Value by Functional Type (US$ Million), 2021–2032
Figure 9. Global mRNA Synthesis Kit Market Share by Functional Type: 2025 vs 2032
Figure 10. IVT Kit Product Picture
Figure 11. Capping Kit Product Picture
Figure 12. Poly(A) Kit Product Picture
Figure 13. Purification Kit Product Picture
Figure 14. All-in-one Kit Product Picture
Figure 15. Global mRNA Synthesis Kit Market Value by Yield Scale (US$ Million), 2021–2032
Figure 16. Global mRNA Synthesis Kit Market Share by Yield Scale: 2025 vs 2032
Figure 17. Low-yield Kit (µg scale) Product Picture
Figure 18. Medium-yield Kit (mg scale) Product Picture
Figure 19. High-yield Kit (multi-mg to g scale) Product Picture
Figure 20. Global mRNA Synthesis Kit Market Value by Application (US$ Million), 2021–2032
Figure 21. Global mRNA Synthesis Kit Market Share by Application: 2025 & 2032
Figure 22. Clinical
Figure 23. Research
Figure 24. Others
Figure 25. Global mRNA Synthesis Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global mRNA Synthesis Kit Market Size (US$ Million), 2021–2032
Figure 27. Global mRNA Synthesis Kit Sales (K Units), 2021–2032
Figure 28. Global mRNA Synthesis Kit Average Price (US$/Unit), 2021–2032
Figure 29. mRNA Synthesis Kit Report Years Considered
Figure 30. mRNA Synthesis Kit Sales Share by Manufacturers in 2025
Figure 31. Global mRNA Synthesis Kit Revenue Share by Manufacturers in 2025
Figure 32. Top 5 and Top 10 Global mRNA Synthesis Kit Players: Market Share by Revenue in mRNA Synthesis Kit in 2025
Figure 33. mRNA Synthesis Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 34. Global mRNA Synthesis Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 35. North America mRNA Synthesis Kit Sales Market Share by Country (2021–2032)
Figure 36. North America mRNA Synthesis Kit Revenue Market Share by Country (2021–2032)
Figure 37. United States mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Canada mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Europe mRNA Synthesis Kit Sales Market Share by Country (2021–2032)
Figure 40. Europe mRNA Synthesis Kit Revenue Market Share by Country (2021–2032)
Figure 41. Germany mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. France mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. U.K. mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Italy mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Russia mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Asia Pacific mRNA Synthesis Kit Sales Market Share by Region (2021–2032)
Figure 47. Asia Pacific mRNA Synthesis Kit Revenue Market Share by Region (2021–2032)
Figure 48. China mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Japan mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. South Korea mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. India mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Australia mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. China Taiwan mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Southeast Asia mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America mRNA Synthesis Kit Sales Market Share by Country (2021–2032)
Figure 56. Latin America mRNA Synthesis Kit Revenue Market Share by Country (2021–2032)
Figure 57. Mexico mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Colombia mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Middle East and Africa mRNA Synthesis Kit Sales Market Share by Country (2021–2032)
Figure 62. Middle East and Africa mRNA Synthesis Kit Revenue Market Share by Country (2021–2032)
Figure 63. Turkey mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Saudi Arabia mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. UAE mRNA Synthesis Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. Global Sales Market Share of mRNA Synthesis Kit by Purity / Regulatory Grade (2021–2032)
Figure 67. Global Revenue Market Share of mRNA Synthesis Kit by Purity / Regulatory Grade (2021–2032)
Figure 68. Global mRNA Synthesis Kit Price (US$/Unit) by Purity / Regulatory Grade (2021–2032)
Figure 69. Global Sales Market Share of mRNA Synthesis Kit by Application (2021–2032)
Figure 70. Global Revenue Market Share of mRNA Synthesis Kit by Application (2021–2032)
Figure 71. Global mRNA Synthesis Kit Price (US$/Unit) by Application (2021–2032)
Figure 72. mRNA Synthesis Kit Value Chain
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
